| A novel multiple-stage antimalarial agent that inhibits protein synthesis B Baragaña, I Hallyburton, MCS Lee, NR Norcross, R Grimaldi, TD Otto, ... Nature 522 (7556), 315-320, 2015 | 456 | 2015 |
| A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax … BE Barber, T William, MJ Grigg, J Menon, S Auburn, J Marfurt, NM Anstey, ... Clinical infectious diseases 56 (3), 383-397, 2013 | 325 | 2013 |
| Identification and Differentiation of Leishmania Species in Clinical Samples by PCR Amplification of the Miniexon Sequence and Subsequent Restriction Fragment … J Marfurt, A Nasereddin, I Niederwieser, CL Jaffe, HP Beck, I Felger Journal of clinical microbiology 41 (7), 3147-3153, 2003 | 300 | 2003 |
| Genomic epidemiology of artemisinin resistant malaria MalariaGEN Plasmodium falciparum Community Project elife 5, e08714, 2016 | 269 | 2016 |
| Quinolone-3-diarylethers: a new class of antimalarial drug A Nilsen, AN LaCrue, KL White, IP Forquer, RM Cross, J Marfurt, ... Science translational medicine 5 (177), 177ra37-177ra37, 2013 | 252 | 2013 |
| Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP J Marfurt, I Niederwieser, ND Makia, HP Beck, I Felger Diagnostic microbiology and infectious disease 46 (2), 115-124, 2003 | 204 | 2003 |
| Genomic analysis of local variation and recent evolution in Plasmodium vivax RD Pearson, R Amato, S Auburn, O Miotto, J Almagro-Garcia, ... Nature genetics 48 (8), 959-964, 2016 | 188 | 2016 |
| KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission KL Kuhen, AK Chatterjee, M Rottmann, K Gagaring, R Borboa, ... Antimicrobial agents and chemotherapy 58 (9), 5060-5067, 2014 | 172 | 2014 |
| Lack of occurrence of severe lupus nephritis among anti‐C1q autoantibody–negative patients M Trendelenburg, J Marfurt, I Gerber, A Tyndall, JA Schifferli Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 169 | 1999 |
| Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum AB Vaidya, JM Morrisey, Z Zhang, S Das, TM Daly, TD Otto, NJ Spillman, ... Nature communications 5 (1), 5521, 2014 | 153 | 2014 |
| Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial WRJ Taylor, K Thriemer, L von Seidlein, P Yuentrakul, T Assawariyathipat, ... The Lancet 394 (10202), 929-938, 2019 | 140 | 2019 |
| An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples A Ahouidi, M Ali, J Almagro-Garcia, A Amambua-Ngwa, C Amaratunga, ... Wellcome Open Research 6, 2021 | 132 | 2021 |
| Evaluation of Plasmodium vivax Genotyping Markers for Molecular Monitoring in Clinical Trials C Koepfli, I Mueller, J Marfurt, M Goroti, A Sie, O Oa, B Genton, HP Beck, ... The Journal of infectious diseases 199 (7), 1074-1080, 2009 | 125 | 2009 |
| Emergence of artemisinin-resistant Plasmodium falciparum with kelch13 C580Y mutations on the island of New Guinea O Miotto, M Sekihara, SI Tachibana, M Yamauchi, RD Pearson, R Amato, ... PLoS Pathogens 16 (12), e1009133, 2020 | 112 | 2020 |
| Molecular Markers of In Vivo Plasmodium vivax Resistance to Amodiaquine Plus Sulfadoxine-Pyrimethamine: Mutations in pvdhfr and pvmdr1 J Marfurt, F de Monbrison, S Brega, L Barbollat, I Müller, A Sie, M Goroti, ... The Journal of infectious diseases 198 (3), 409-417, 2008 | 96 | 2008 |
| A triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with improved drug-like properties for treatment and prevention of malaria MA Phillips, KL White, S Kokkonda, X Deng, J White, F El Mazouni, ... ACS infectious diseases 2 (12), 945-957, 2016 | 88 | 2016 |
| Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax RN Price, S Auburn, J Marfurt, Q Cheng Trends in parasitology 28 (11), 522-529, 2012 | 87 | 2012 |
| Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea J Marfurt, I Müeller, A Sie, P Maku, M Goroti, JC Reeder, HP Beck, ... American Journal of Tropical Medicine and Hygiene 77 (5), 947-954, 2007 | 78 | 2007 |
| The Plasmodium falciparum transcriptome in severe malaria reveals altered expression of genes involved in important processes including surface antigen–encoding var genes GQ Tonkin-Hill, L Trianty, R Noviyanti, HHT Nguyen, BF Sebayang, ... PLoS biology 16 (3), e2004328, 2018 | 76 | 2018 |
| Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group K Thriemer, B Ley, A Bobogare, L Dysoley, MS Alam, AP Pasaribu, ... Malaria journal 16, 1-9, 2017 | 74 | 2017 |
